Protea Biosciences is a bioanalytics technology company focused on protein characterization, proteomics, metabolomics, and small molecule analysis. Using instrumentation including high resolution, accurate mass (HRAM) mass spectrometry systems, Direct Ionization System. Protea supports researchers' projects by providing information to accelerate drug discovery and development. Their infrastructure and workflows enable the identification, quantification, characterization, and spatial distribution of biomolecules such as proteins, metabolites, and lipids from biological matrices. Protea's analyses include proprietary sample preparation methods, method development, and data analysis. Their customers use this molecular information to achieve their study objectives in the fields of pharmaceutical, clinical, academic, and industrial research.
Protea offers a line of mass spectrometry standards and protein sample preparation products which include and mass spec grade protein standards.
Protea Biosciences focuses on mass spectrometry based identification, quantification, characterization and distribution of biomolecules such as proteins, metabolites, and lipids from biological matrices to provide insights into biological processes.
They offer technologies and capabilities to their clients to characterize the types of biologically active molecules using a variety of mass spectrometry tools and workflows. Protea also provides mass spectrometry imaging technologies (LAESI DP-1000 Direct Ionization System).
Documentaries, videos and podcasts
- Cluster: Synthetic biologyA cluster of topics related to synthetic biology.
- Cluster: BiotechnologyA cluster of topics related to biotechnology.
- CompanyA company, abbreviated 'co.', is a legal entity made up of an association of people, be they natural, legal, or a mixture of both, for carrying on a commercial or industrial enterprise.